Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzan M Hammond

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Molecular Therapeutics|August 3, 2010
PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophySuzan M Hammond, Matthew Ja Wood
Trends in Genetics : TIG|April 19, 2011
Genetic therapies for RNA mis-splicing diseasesSuzan M Hammond, Matthew J A Wood
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Evaluating Efficacy of Peptide-Delivered Oligonucleotides Using the Severe Taiwanese SMA Mouse ModelLarissa Goli, Jessica Stoodley, Suzan M Hammond, et al.
Leukemia Research|November 16, 2004
Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemiaSuzan M Hammond, Scott C Crable, Kathleen P Anderson
Biochemical and Biophysical Research Communications|December 8, 2009
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophyRocky G Gogliotti, Suzan M Hammond, Cathleen Lutz, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular AtrophySuzan M Hammond, Frank Abendroth, Michael J Gait, et al.
Current Gene Therapy|April 27, 2012
Use of cell-penetrating-peptides in oligonucleotide splice switching therapySamir A El Andaloussi, Suzan M Hammond, Imre Mäger, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing tissue-specific antisense oligonucleotide-peptide conjugatesCorinne A Betts, Suzan M Hammond, Hai-Fang Yin, et al.
Plos One|January 21, 2011
Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not lateSuzan M Hammond, Rocky G Gogliotti, Vamshi Rao, et al.
Nucleic Acid Therapeutics|January 25, 2017
Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular AtrophyFazel Shabanpoor, Suzan M Hammond, Frank Abendroth, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|August 3, 2010
PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophySuzan M Hammond, Matthew Ja Wood
Trends in Genetics : TIG|April 19, 2011
Genetic therapies for RNA mis-splicing diseasesSuzan M Hammond, Matthew J A Wood
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Evaluating Efficacy of Peptide-Delivered Oligonucleotides Using the Severe Taiwanese SMA Mouse ModelLarissa Goli, Jessica Stoodley, Suzan M Hammond, et al.
Leukemia Research|November 16, 2004
Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemiaSuzan M Hammond, Scott C Crable, Kathleen P Anderson
Biochemical and Biophysical Research Communications|December 8, 2009
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophyRocky G Gogliotti, Suzan M Hammond, Cathleen Lutz, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular AtrophySuzan M Hammond, Frank Abendroth, Michael J Gait, et al.
Current Gene Therapy|April 27, 2012
Use of cell-penetrating-peptides in oligonucleotide splice switching therapySamir A El Andaloussi, Suzan M Hammond, Imre Mäger, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing tissue-specific antisense oligonucleotide-peptide conjugatesCorinne A Betts, Suzan M Hammond, Hai-Fang Yin, et al.
Plos One|January 21, 2011
Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not lateSuzan M Hammond, Rocky G Gogliotti, Vamshi Rao, et al.
Nucleic Acid Therapeutics|January 25, 2017
Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular AtrophyFazel Shabanpoor, Suzan M Hammond, Frank Abendroth, et al.
Pageof 3